These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 14742220)

  • 21. Evernimicin (SCH27899) inhibits both translation and 50S ribosomal subunit formation in Staphylococcus aureus cells.
    Champney WS; Tober CL
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1413-7. PubMed ID: 10817686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New roles of fluoxetine in pharmacology: Antibacterial effect and modulation of antibiotic activity.
    Karine de Sousa A; Rocha JE; Gonçalves de Souza T; Sampaio de Freitas T; Ribeiro-Filho J; Melo Coutinho HD
    Microb Pathog; 2018 Oct; 123():368-371. PubMed ID: 30056107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and antimicrobial evaluation of TAN-1057A/B analogs.
    Williams RM; Yuan C; Lee VJ; Chamberland S
    J Antibiot (Tokyo); 1998 Feb; 51(2):189-201. PubMed ID: 9544941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mode of action of the cyclic depsipeptide antibiotic LL-AO341 beta 1 and partial characterization of a Staphylococcus aureus mutant resistant to the antibiotic.
    Oliva B; Maiese WM; Greenstein M; Borders DB; Chopra I
    J Antimicrob Chemother; 1993 Dec; 32(6):817-30. PubMed ID: 7511579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Staphylococcus aureus with an erm-mediated constitutive macrolide-lincosamide-streptogramin B resistance phenotype has reduced susceptibility to the new ketolide, solithromycin.
    Yao W; Xu G; Li D; Bai B; Wang H; Cheng H; Zheng J; Sun X; Lin Z; Deng Q; Yu Z
    BMC Infect Dis; 2019 Feb; 19(1):175. PubMed ID: 30782125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ribosomal and non-ribosomal resistance to oxazolidinones: species-specific idiosyncrasy of ribosomal alterations.
    Sander P; Belova L; Kidan YG; Pfister P; Mankin AS; Böttger EC
    Mol Microbiol; 2002 Dec; 46(5):1295-304. PubMed ID: 12453216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding of novel macrolide structures to macrolides-lincosamides-streptogramin B-resistant ribosomes inhibits protein synthesis and bacterial growth.
    Goldman RC; Kadam SK
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1058-66. PubMed ID: 2506804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retapamulin inhibition of translation and 50S ribosomal subunit formation in Staphylococcus aureus cells.
    Champney WS; Rodgers WK
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3385-7. PubMed ID: 17562806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross resistance of Escherichia coli B ribosomes to inhibition of the puromycin reaction by erythromycin, spiramycin and chloramphenicol.
    Cerná J; Rychlík I
    Biochim Biophys Acta; 1968 Apr; 157(2):436-8. PubMed ID: 4870247
    [No Abstract]   [Full Text] [Related]  

  • 30. Bactericidal effect of bovine lactoferrin, LFcin, LFampin and LFchimera on antibiotic-resistant Staphylococcus aureus and Escherichia coli.
    Flores-Villaseñor H; Canizalez-Román A; Reyes-Lopez M; Nazmi K; de la Garza M; Zazueta-Beltrán J; León-Sicairos N; Bolscher JG
    Biometals; 2010 Jun; 23(3):569-78. PubMed ID: 20195887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diverse effects of residues 74-78 in ribosomal protein S12 on decoding and antibiotic sensitivity.
    Agarwal D; O'Connor M
    Biochem Biophys Res Commun; 2014 Mar; 445(2):475-9. PubMed ID: 24530394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid Determination of Resistance to Antibiotic Inhibitors of Protein Synthesis in Staphylococcus aureus Through In Situ Evaluation of DNase Activity.
    Otero F; Santiso R; López I; Touzón I; Gosálvez J; Bou G; Fernández JL
    Microb Drug Resist; 2018; 24(6):739-746. PubMed ID: 29608387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening of extracts of algae from Baja California sur, Mexico as reversers of the antibiotic resistance of some pathogenic bacteria.
    Muñoz-Ochoa M; Murillo-Alvarez JI; Zermeño-Cervantes LA; Martínez-Diaz S; Rodríguez-Riosmena R
    Eur Rev Med Pharmacol Sci; 2010 Sep; 14(9):739-47. PubMed ID: 21061832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of Staphylococcus aureus isolates identified as erythromycin intermediate by the Vitek-1 System: comparison with results obtained with the Vitek-2 and Phoenix systems.
    Tang P; Low DE; Atkinson S; Pike K; Ashi-Sulaiman A; Simor A; Richardson S; Willey BM
    J Clin Microbiol; 2003 Oct; 41(10):4823-5. PubMed ID: 14532232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacterial isolation and antibiotic susceptibility from diabetic foot ulcers in Kenya using microbiological tests and comparison with RT-PCR in detection of S. aureus and MRSA.
    Mutonga DM; Mureithi MW; Ngugi NN; Otieno FCF
    BMC Res Notes; 2019 Apr; 12(1):244. PubMed ID: 31036061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ketolide antibiotic ABT-773 is a specific inhibitor of translation and 50S ribosomal subunit formation in Streptococcus pneumoniae cells.
    Champney WS; Pelt J
    Curr Microbiol; 2002 Sep; 45(3):155-60. PubMed ID: 12177734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic susceptibility patterns of community- and hospital-acquired Staphylococcus aureus and Escherichia coli in Estonia.
    Karki T; Truusalu K; Vainumäe I; Mikelsaar M
    Scand J Infect Dis; 2001; 33(5):333-8. PubMed ID: 11440217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TAN-1057A: a translational inhibitor with a specific inhibitory effect on 50S ribosomal subunit formation.
    Champney WS; Pelt J; Tober CL
    Curr Microbiol; 2001 Nov; 43(5):340-5. PubMed ID: 11688798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of the primary target of a quinolone drug and the effect of quinolone resistance-conferring mutations by measuring quinolone sensitivity based on its mode of action.
    Pfeiffer ES; Hiasa H
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3410-2. PubMed ID: 17606687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Erythromycin-induced resistance to clindamycin in Staphylococcus aureus.
    Marr JK; Lim AT; Yamamoto LG
    Hawaii Med J; 2005 Jan; 64(1):6-8. PubMed ID: 15751751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.